Dissecting the molecular control of immune cell accumulation in the inflamed joint.
Arthritis
Autoimmune diseases
Autoimmunity
Cell migration/adhesion
Inflammation
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
08 04 2022
08 04 2022
Historique:
pubmed:
23
2
2022
medline:
12
4
2022
entrez:
22
2
2022
Statut:
epublish
Résumé
Mechanisms governing entry and exit of immune cells into and out of inflamed joints remain poorly understood. We sought herein to identify the key molecular pathways regulating such migration. Using murine models of inflammation in conjunction with mice expressing a photoconvertible fluorescent protein, we characterized the migration of cells from joints to draining lymph nodes and performed RNA-Seq analysis on isolated cells, identifying genes associated with migration and retention. We further refined the gene list to those specific for joint inflammation. RNA-Seq data revealed pathways and genes previously highlighted as characteristic of rheumatoid arthritis in patient studies, validating the methodology. Focusing on pathways associated with cell migration, adhesion, and movement, we identified genes involved in the retention of immune cells in the inflamed joint, namely junctional adhesion molecule A (JAM-A), and identified a role for such molecules in T cell differentiation in vivo. Thus, using a combination of cell-tracking approaches and murine models of inflammatory arthritis, we identified genes, pathways, and anatomically specific tissue signatures regulating cell migration in a variety of inflamed sites. This skin- and joint-specific data set will be an invaluable resource for the identification of therapeutic targets for arthritis and other inflammatory disorders.
Identifiants
pubmed: 35192549
pii: 151281
doi: 10.1172/jci.insight.151281
pmc: PMC9057592
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Versus Arthritis
ID : 19788
Pays : United Kingdom
Références
Front Immunol. 2020 Nov 25;11:602094
pubmed: 33324419
Clin Immunol. 2017 Feb;175:10-15
pubmed: 27890706
Ann Rheum Dis. 2018 Apr;77(4):579-588
pubmed: 29358281
Front Immunol. 2017 Nov 24;8:1627
pubmed: 29225602
Int Immunol. 2008 Jul;20(7):911-23
pubmed: 18495625
Arthritis Rheum. 2005 Dec;52(12):3718-30
pubmed: 16320322
Mol Biol Cell. 2013 Apr;24(7):933-44
pubmed: 23389628
Front Immunol. 2018 Nov 22;9:2684
pubmed: 30524434
Arthritis Rheum. 2001 Dec;44(12):2750-60
pubmed: 11762935
Trends Immunol. 2013 Dec;34(12):602-9
pubmed: 23631936
J Cell Biol. 1998 Jul 13;142(1):117-27
pubmed: 9660867
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10871-6
pubmed: 18663225
Arthritis Res Ther. 2005;7(2):R256-67
pubmed: 15743472
Ann Rheum Dis. 2013 Mar;72(3):337-44
pubmed: 22589376
Ann Rheum Dis. 2006 Mar;65(3):294-300
pubmed: 16107514
Immunol Lett. 2021 Jul;235:32-40
pubmed: 34000305
J Clin Invest. 2004 Sep;114(5):729-38
pubmed: 15343392
J Immunol. 2015 Nov 1;195(9):4126-35
pubmed: 26416269
Arthritis Rheum. 2001 May;44(5):1022-32
pubmed: 11352233
Rheumatology (Oxford). 2016 Mar;55(3):564-72
pubmed: 26475798
J Immunol. 2005 Mar 15;174(6):3668-75
pubmed: 15749905
Arthritis Rheum. 2009 Dec;60(12):3572-81
pubmed: 19950299
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Biophys J. 2009 Jan;96(1):285-93
pubmed: 18849408
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Front Immunol. 2019 Apr 05;10:598
pubmed: 31024523
J Immunol. 2004 Jul 1;173(1):151-6
pubmed: 15210769
BMC Bioinformatics. 2021 Aug 19;22(1):411
pubmed: 34412594
J Immunol. 2004 Nov 15;173(10):6259-64
pubmed: 15528364
Eur J Immunol. 2014 Jun;44(6):1633-43
pubmed: 24700244
J Immunol. 2007 Dec 15;179(12):8463-9
pubmed: 18056393
J Exp Med. 2005 Jan 17;201(2):291-301
pubmed: 15657295
Nature. 2004 Jan 22;427(6972):355-60
pubmed: 14737169